<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34162913</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.</ArticleTitle><Pagination><StartPage>13153</StartPage><MedlinePgn>13153</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13153</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-92045-x</ELocationID><Abstract><AbstractText>Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a "long COVID" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants received a digital questionnaire on demographics and COVID-19-related symptoms. Persistent symptoms: symptoms &gt;&#x2009;4&#xa0;weeks (in sensitivity analyses &gt;&#x2009;12&#xa0;weeks). We included 445 participants, of whom 34% were asymptomatic. Most common acute symptoms were fatigue, headache, and sneezing, while fatigue and reduced smell and taste were most severe. Persistent symptoms, most commonly fatigue and memory and concentration difficulties, were reported by 36% of 198 symptomatic participants with follow-up &gt;&#x2009;4&#xa0;weeks. Risk factors for persistent symptoms included female sex (women 44% vs. men 24%, odds ratio 2.7, 95% CI 1.4-5.1, p&#x2009;=&#x2009;0.003) and BMI (odds ratio 1.1, 95% CI 1.0-1.2, p&#x2009;=&#x2009;0.001). In conclusion, among non-hospitalized PCR-confirmed COVID-19 patients one third were asymptomatic while one third of symptomatic participants had persistent symptoms illustrating the heterogeneity of disease presentation. These findings should be considered in health care planning and policy making related to COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bliddal</LastName><ForeName>Sofie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Banasik</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Ole Birger</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nissen</LastName><ForeName>Janna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantwell</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwinn</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulstrup</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westergaard</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Recurrent Pregnancy Loss Unit, Department of Fertility, Copenhagen University Hospital, Rigshospitalet, Fertility Clinic 4071, 2100, Copenhagen &#xd8;, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Recurrent Pregnancy Loss Unit, Department of Obstetrics and Gynecology, Hvidovre Hospital, 2650, Hvidovre, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Methods and Analysis, Statistics Denmark, 2100, Copenhagen &#xd8;, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullum</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Management Section, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunak</LastName><ForeName>S&#xf8;ren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tommerup</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feenstra</LastName><ForeName>Bjarke</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geller</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>Sisse Rye</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xf8;nb&#xe6;k</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hematology, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Claus Henrik</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Susanne Dam</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feldt-Rasmussen</LastName><ForeName>Ulla</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark. ufeldt@rh.dk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark. ufeldt@rh.dk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020-0178</GrantID><Agency>Sygesikring Danmark</Agency><Country/></Grant><Grant><GrantID>NNF14CC0001</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant><Grant><GrantID>NNF17OC0027594</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant><Grant><GrantID>Denmark</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant><Grant><GrantID>0216-00014B</GrantID><Agency>Independent Research Fund Denmark</Agency><Country/></Grant><Grant><GrantID>Denmark</GrantID><Agency>Independent Research Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34162913</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-92045-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins University. The Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. (2021).</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, et al. Risk factors of critical &amp; mortal COVID-19 cases: A systematic literature review and meta-analysis. J. Infect. 2020;81:e16&#x2013;e25. doi: 10.1016/j.jinf.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE. 2020;15:e0234765. doi: 10.1371/journal.pone.0234765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234765</ArticleId><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronbichler A, et al. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020;98:180&#x2013;186. doi: 10.1016/j.ijid.2020.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.052</ArticleId><ArticleId IdType="pmc">PMC7832751</ArticleId><ArticleId IdType="pubmed">32562846</ArticleId></ArticleIdList></Reference><Reference><Citation>Arons MM, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 2020;382:2081&#x2013;2090. doi: 10.1056/NEJMoa2008457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008457</ArticleId><ArticleId IdType="pmc">PMC7200056</ArticleId><ArticleId IdType="pubmed">32329971</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser E. Long term respiratory complications of COVID-19. BMJ. 2020;370:m3001. doi: 10.1136/bmj.m3001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3001</ArticleId><ArticleId IdType="pubmed">32747332</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, et al. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2020 doi: 10.4193/Rhin20.544.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.544</ArticleId><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjaeldstad, A. W. Prolonged complaints of chemosensory loss after COVID-19. Dan. Med. J.67, A05200340 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32741438</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. 2020;15:e0243882. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397, 220&#x2013;232 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID consortium &amp; Leicester University. The Post-hospitalisation COVID-19 study (PHOSP-COVID). https://www.phosp.org/. 2020).</Citation></Reference><Reference><Citation>The Lancet Facing up to long COVID. Lancet. 2020;396:1861. doi: 10.1016/S0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Navabi. Long covid: How to define it and how to manage it. BMJ.370, m3489 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature Long COVID: Let patients help define long-lasting COVID symptoms. Nature. 2020;586:170. doi: 10.1038/d41586-020-02796-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188/chapter/1-Identifying-people-with-ongoing-symptomatic-COVID-19-or-post-COVID-19-syndrome. (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Meys, R. et al. Generic and Respiratory-Specific Quality of Life in Non-Hospitalized Patients with COVID-19. J. Clin. Med.9, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764406</ArticleId><ArticleId IdType="pubmed">33317214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, et al. Persistent symptoms after COVID-19: Qualitative study of 114 "long COVID" patients and draft quality principles for services. BMC. Health Serv. Res. 2020;20:1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>The Danish Digitization Agency. Statistics on Digital Post. https://digst.dk/it-loesninger/digital-post/om-loesningen/tal-og-statistik-om-digital-post/. (2020).</Citation></Reference><Reference><Citation>Voldstedlund, M., Haarh, M., &amp; Molbak, K. MiBa Board of Representatives. Euro. Surveill. 19, 20667 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24434175</ArticleId></ArticleIdList></Reference><Reference><Citation>Statens Serum Institut. The Danish National Biobank. https://www.danishnationalbiobank.com/. (2021). (Accessed 22 Dec 2020)</Citation></Reference><Reference><Citation>Statens Serum Institut. The Danish National Biobank. https://www.danishnationalbiobank.com/. (2020).</Citation></Reference><Reference><Citation>The Capital Region of Denmark. The Copenhagen Hospital Biobank. https://www.regionh.dk/forskning-og-innovation/Region-Hovedstadens-biobank/Sider/default.aspx. (2020). (Accessed 22 Dec 2020)</Citation></Reference><Reference><Citation>Pedersen, O. B. et al. SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors&#x2014;A cross-sectional study. Clin. Infect. Dis.26, ciaa1627 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665387</ArticleId><ArticleId IdType="pubmed">33103182</ArticleId></ArticleIdList></Reference><Reference><Citation>Statens Serum Institut. Influmeter. https://www.ssi.dk/aktuelt/nyheder/2020/vil-du-hjaelpe-statens-serum-institut-med-at-overvaage-influenza-og-covid19. (2020). (Accessed 10 May 2021)</Citation></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/. (2021).</Citation></Reference><Reference><Citation>Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. https://www.medrxiv.org/content/10.1101/2020.12.24.20248802v2. (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802v2</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst, B. et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin. Infect. Dis., ciaa1750 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal, S. et al. 'Long-COVID': A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 10.1136/thoraxjnl-2020-215818 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen, M. S. et al. Long COVID in the Faroe Islands&#x2014;a longitudinal study among non-hospitalized patients. Clin. Infect. Dis., ciaa1792, 10.1093/cid/ciaa1792 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli, E. T. et al. Long-term COVID-19 symptoms in a large unselected population. https://www.medrxiv.org/content/10.1101/2020.10.07.20208702v3. (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702v3</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre, C. H. et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. https://www.medrxiv.org/content/10.1101/2020.10.19.20214494v2. (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.19.20214494v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient-Led Research for COVID-19. Report: What does COVID-19 recovery actually look like? https://patientresearchcovid19.com/research/report-1/. (2021).</Citation></Reference><Reference><Citation>Goertz, Y. M. J. et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ. Open. Res.6, 00542 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh-Messinger, J. et al. The Kids Are Not Alright: A Preliminary Report of Post-COVID Syndrome in University Students. https://www.medrxiv.org/content/10.1101/2020.11.24.20238261v2.full.pdf. (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.24.20238261v2.full.pdf</ArticleId><ArticleId IdType="pmc">PMC8742843</ArticleId><ArticleId IdType="pubmed">34242539</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature Medicine Meeting the challenge of long COVID. Nat. Med. 2020;26:1803. doi: 10.1038/s41591-020-01177-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01177-6</ArticleId><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>Metlay JP, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J. Gen. Intern. Med. 1997;12:423&#x2013;430. doi: 10.1046/j.1525-1497.1997.00074.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.1997.00074.x</ArticleId><ArticleId IdType="pmc">PMC1497132</ArticleId><ArticleId IdType="pubmed">9229281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey CM, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 2007;167:1312&#x2013;1320. doi: 10.1001/archinte.167.12.1312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.12.1312</ArticleId><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Billi AC, Kahlenberg JM, Gudjonsson JE. Sex bias in autoimmunity. Curr. Opin. Rheumatol. 2019;31:53&#x2013;61. doi: 10.1097/BOR.0000000000000564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000564</ArticleId><ArticleId IdType="pmc">PMC6296774</ArticleId><ArticleId IdType="pubmed">30394940</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner-Stokes L, Wade DT. Updated NICE guidance on chronic fatigue syndrome. BMJ. 2020;371:m4774. doi: 10.1136/bmj.m4774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4774</ArticleId><ArticleId IdType="pubmed">33328173</ArticleId></ArticleIdList></Reference><Reference><Citation>Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane. Database. Syst. Rev. 2019;10:CD003200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953363</ArticleId><ArticleId IdType="pubmed">31577366</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink, M. &amp; Vink-Niese, A. Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome. Healthcare. (Basel). 8, 552 2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Support for Rehabilitation: Self-Management after COVID-19 Related Illness. https://www.who.int/publications/m/item/support-for-rehabilitation-self-management-after-covid-19-related-illness. (2020).</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna, R. et al. Long COVID guidelines need to reflect lived experience. Lancet. 397, 455&#x2013;457(2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Drew DA, et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020;368:1362&#x2013;1367. doi: 10.1126/science.abc0473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc0473</ArticleId><ArticleId IdType="pmc">PMC7200009</ArticleId><ArticleId IdType="pubmed">32371477</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen K, et al. Risk of COVID-19 in health-care workers in Denmark: An observational cohort study. Lancet Infect. Dis. 2020;20:1401&#x2013;1408. doi: 10.1016/S1473-3099(20)30589-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30589-2</ArticleId><ArticleId IdType="pmc">PMC7398038</ArticleId><ArticleId IdType="pubmed">32758438</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbjartsson DF, et al. Spread of SARS-CoV-2 in the Icelandic Population. N. Engl. J. Med. 2020;382:2302&#x2013;2315. doi: 10.1056/NEJMoa2006100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2006100</ArticleId><ArticleId IdType="pmc">PMC7175425</ArticleId><ArticleId IdType="pubmed">32289214</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson MA, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw. Open. 2021;4:e2035057. doi: 10.1001/jamanetworkopen.2020.35057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.35057</ArticleId><ArticleId IdType="pmc">PMC7791354</ArticleId><ArticleId IdType="pubmed">33410879</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>